Decrease in specific micronutrient intake in colorectal cancer patients with tumors presenting Ki-ras mutation

Anticancer Research

Volumn 24, Issue 3 B, 2004, Pages 2011-2020

  Laso, Nuria ^a   Mas, Sergi ^a   Lafuente, M Jose ^a   Casterad, Xavier ^a   Trias, Manuel ^b   Ballesta, Antonio ^c   Molina, Rafael ^c   Salas, Jordi ^d   Ascaso, Carlos ^a   Zheng, Shichun ^e   Wiencke, John K ^e   Lafuente, Amalia ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Hospital St Pau   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Colorectal cancer risk; Diet; Iron; Ki ras; Thiamine; Vitamin A; Vitamin D

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; CYANOCOBALAMIN; FOLIC ACID; IRON; MAGNESIUM; POTASSIUM; PYRIDOXINE; RETINOL; RIBOFLAVIN; SODIUM; THIAMINE; TRACE ELEMENT; VITAMIN D; ZINC;

ADULT; AGED; ARTICLE; CODON; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOOD PREFERENCE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HIGH FIBER DIET; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; NUTRIENT; ONCOGENE KI RAS; ONCOGENE RAS; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RISK FACTOR; STATISTICAL SIGNIFICANCE; VITAMIN INTAKE;

AGED; AVITAMINOSIS; CASE-CONTROL STUDIES; COCARCINOGENESIS; COLORECTAL NEOPLASMS; DIET; DIETARY FIBER; FEMALE; FOLIC ACID DEFICIENCY; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRON; MALE; MICRONUTRIENTS; MIDDLE AGED; MUTATION; POTASSIUM DEFICIENCY;

EID: 3242738556     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Slattery ML, Friedman GD, Potter JD, Edwards S, Caan BJ and Samowitz WA: A description of age, sex, and site distributions of colon carcinoma in three geographic areas. Cancer 78: 1666-1670, 1996.
2. Potter JD, Slattery ML, Bostick RM and Gapstur SM: Colon cancer: a review of the epidemiology. Epidemiol Rev 15: 499-545, 1993.
3. Bufill JA: Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1134: 779-788, 1990.
4. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Presinger BA, Leppert M, Nakamura Y, White R, Smits AMM and Boss JL: Genetic alterations during colorectal-tumor development. New Engl J Med 319: 525-532, 1988.
5. Rashid A, Zahurak M, Goodman SN and Hamilton SR: Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas. Gut 44: 826-833, 1999.
6. Tortola S, Marcuello E, Gonzalez L, Reyes G, Arribas R, Aiza G, Sancho FJ, Peinado MA and Capella G: P53 and K-ras gene mutations correlate with tumour aggressiveness but are not of routine prognostic value in colorectal cancer. J Clin Oncol 17: 1375-1381, 1999.
7. Fearon ER: Molecular genetic studies of the adenoma-carcinoma sequence. Adv Intern Med 39: 123-146, 1994.
8. Bos JL, Fearon ER, Hamilton ER, Verlaande Vries M, Vander Eb AJ and Vogelstein B: Prevalence of ras mutations in human colorectal cancers. Nature 327: 293-297, 1987.
9. Fearon ER and Vogelstein BA: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
10. Bautista D, Obrador A, Moreno V, Cabeza E, Canet R, Benito E, Bosch X and Costa J: Ki-ras mutation modifies the protective effect of dietary monounsaturated fat and calcium on sporadic colorectal cancer. Cancer Epidem Biomar 6: 57-61, 1997.
11. Martínez ME, Maltzman T, Marshall JR, Einspahr J, Reid ME, Sampliner R, Abnen DJ, Hamilton SR and Alberts DS: Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas. Cancer Res 59: 5181-5185, 1999.
12. Slattery ML, Curtin K, Anderson K, Ma KN, Edwards S, Leppert M, Potter J, Schaffer D and Sannowitz WS: Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study. Cancer Res 60: 6935-6941, 2000.
13. Lafuente MJ, Casterad X, Trias M, Ascaso C, Molina R, Ballesta A, Zheng S, Wiencke JK and Lafuente A: NAD(P)H: quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors. Carcinogenesis 21: 1813-1819, 2000.
14. Laso N, Lafuente MJ, Mas S, Trias M, Ascaso C, Molina R, Ballesta A, Rodriguez F and Lafuente A: Glutathione S-transferase (GSTM1 and GSTT1)- dependent risk for colorectal cancer. Anticancer Res 22: 3399-3404, 2002.
15. Martin Moreno JM, Boyle P, Gorgojo L, Maisonneuve P, Fernandez-Rodriguez JC, Salvini S and Willett WC: Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 22: 512-519, 1993.
16. Aguilar M: Dietetica: un programa para la nutricion, version 2.0. CONAYCITE. Madrid, 1991.
17. Andujar MM, Moreiras-Varela O and Gil F: Tablas de Composición de Alimentos. Instituto de Nutricion (CSIC). Madrid, 1987.
18. Jiménez A and Cervera P: Tabla de Composición de Alimentos. Laboratorio Wander. Barcelona, 1988.
19. Andujar M, Moreiras-Varela O and Gil F: Tablas de composición de Alimentos. Instituto de Nutrición y Bromatología (CSIC). Madrid, 1990.
20. Nelson HH, Christiani DC, Mark EJ, Wiencke JK, Wain JC and Kelsey KT: Implications and prognostic value of K-ras mutation in early stage lung cancer in women. J Natl Cancer I 91: 2032-2038, 1999.
21. Jacobson DR and Mills NE: A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia. Oncogene 9: 553-563, 1994.
22. Benito E, Stiggelbout A, Bosch FX, Obrador A, Kaldor J, Mulet M and Munoz N: Nutritional factors in colorectal cancer risk: a case-control study in Majorca. Int J Cancer 49: 161-167, 1991.
23. Andreyev HJN, Norman AR, Cunningham D, Oates JR and Clarke PA: Kirsten ras mutations in patients with colorectal cancer: The multicenter "RASCAL" study. J Natl Cancer I 90: 675-684, 1998.
24. Devesa SS and Chow WH: Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 71: 3819-3826, 1993.
25. Harris PJ and Fergusson LR: Dietary fibres may or enhance carcinogenesis. Mutat Res 443: 95-110, 1999.
26. Burkit DS: Related disease-related cause? Lancet 2: 1229-1231, 1969.
27. La Vecchia C, Negri E, Pelucchi C and Franceschi S: Dietary folate and colorectal cancer. Int J Cancer 102: 545-547, 2002.
28. Lipkin M and Newmark H: Calcium and the prevention of colon cancer. J Cell Biochem (Supp) 22: 65-73, 1995.
29. Giovannucci E: Diet, body weight and colorectal cancer: a summary of the epidemiologic evidence. J Women's Health 12: 173-182, 2003.
30. Pritchard RS, Baron JA and Gerhardsson de Verdier M: Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidem Biomar 5: 897-900, 1996.
31. Garland C and Garland FC: Do sunlight and vitamin D reduce the likehood of colon cancer? Int J Epidemiol 27: 155, 1979.
32. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs Ch, Rosner BA, Speizer FE and Willett WC: Multivitamin use, folate and colon cancer in women in the Nurses' Health study. Ann Intern Med 129: 517-524, 1998.
33. Jedrychowski W, Steindorf K, Popiela T, Wahrendorf J, Tobiasz-Adamczyk B, Kulig J and Penar A: Alcohol consumption and the risk of colorectal cancer at low levels of micronutrient intake. Med Sci Monit 8: 357-63, 2002.
34. Ames BN: Dietary carcinogens and anticarcinogens. Science 221: 1256-1263, 1983.
35. Bostick RM, Potter JD, McKenzie DR, Sellers TA, Kushi LH, Steinmetz KA and Folsom AR: Reduced risk of colon cancer with high intake of vitamin E; the Iowa Women's Health Study. Cancer Res 53: 4230-4237, 1993.
36. Freudenheim JL, Graham S, Marshall JR et al: A case-control study of diet and rectal cancer in western New York. Am J Epidemiol 131: 612-624, 1990.
37. Longnecker MP, Martin-Moreno JM, Knekt P, Nomura AM, Schober SE, Stahelin HB, Wald NJ, Gey KF and Willett WC: Serum alpha-tocopherol concentration in relation to subsequent colorectal cancer: pooled data from five cohorts. J Natl Cancer I 84: 430-435.c 473 38, 1992.
38. Ferraroni M, La Vecchia C, D'Avanzo B, Negri E, Franceschi S and Decarli A: Selected micronutrient intake and the risk of colorectal cancer. Br J Cancer 70: 1150-1155, 1994.
39. Roninson IB and Dokmanovic M: Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoids. J Cell Biochem 88: 83-94, 2003.
40. Altucci L and Gronemeyer H: The promise of retinoids to fight against cancer. Nat Rev Cancer 1: 181-193, 2001.
41. Comin-Anduix B, Boren J, Martinez S, Moro C, Centelles JJ, Trebukhina R, Petushok N, Lee WN, Boros LG and Cascante M: The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. Eur J Biochem 268: 4177-4182, 2001.
42. Wurzelmann JL, Silver A, Schreinemachers DM, Sandler RS and Everson RB: Iron intake and the risk of colorectal cancer. Cancer Epidem Biomar 5: 503-507, 1996.
43. Bos JL: Ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689, 1989.
44. Ross JA and Nesnow S: Polycyclic aromatic hydrocarbons: correlations between DNA adducts and ras oncogene mutations. Mutat Res 424: 155-156, 1999.
45. Metton N, Simonetti J and Williams K: Inefficient in vivo repair of mismatches at an oncogenic hotspot correlated with lack of binding by mismatch repair proteins and with phase of the cell cycle. Carcinogenesis 20: 1417-1424, 1999.
46. Custer L, Zajc B, Sayer JM, Cullinane C, Phillips DR, Cheh AM, Jerina DM, Bohr VA and Mazur SJ: Stereospecific differences in repair by human cell extracts of synthesized oligonucleotides containing trans-opened 7,8,9,10-tetrahydrobenzo(a)pyrene 7,8-diol 9,10-epoxide N2-dG adduct stereoisomers located with the human K-ras codon 12 sequence. Biochemistry 38: 569-581, 1999.
47. Kamiya H, Murata-Kamiya N, Koizume S, Inoue H, Nishimura S and Ohtsuka E: 8-hydroxyguanine (7,8-dihydro-8-oxoguanine) in hot spots of the c-Ha-ras gene: effects of sequence contexts on mutation spectra. Carcinogenesis 16: 883-889, 1995.
48. Dove-Edwin I and Thomas HJW: The prevention of colorectal cancer. Aliment Pharm Therap 15: 323-336, 2001.